家禽用細菌病ワクチン市場レポート：2031年までの動向、予測、競合分析

世界の家禽用細菌病ワクチン市場の将来は、NDV、マレック病、IBD、感染性気管支炎、インフルエンザの各市場における機会により有望視されています。世界の家禽用細菌病ワクチン市場は、2025年から2031年にかけてCAGR 7.5%で成長すると予想されます。この市場の主な促進要因は、家禽製品の需要増加、動物の健康に対する意識の高まり、規制要件です。

• Lucintel社の予測によると、タイプ別では、家禽の疾病予防に広く受け入れられていることから、殺処分が予測期間中最大のセグメントであり続ける。
• 用途別では、感染性気管支炎が、その高い流行率と家禽の健康への影響により、最大セグメントであり続けると思われます。
• 地域別では、アジア太平洋は家禽の生産量が多いため、予測期間中に最も高い成長が見込まれます。

150ページ以上の包括的なレポートで、ビジネスの意思決定に役立つ貴重な洞察を得ることができます。いくつかの洞察を含むサンプル図を以下に示します。

家禽用細菌病ワクチン市場の新たな動向

家禽の健康や抗生物質使用への依存に対する関心が高まる中、世界の家禽用細菌病ワクチン市場は様々な新たな動向によって変化しています。ワクチン技術の革新が進み、食品の安全性に対する関心も高まっています。家禽細菌病市場のさらなる変化のために注目される動向は以下の通りである：

• AMRの予防：抗菌剤耐性の問題は養鶏業界を岐路に立たせ、この分野はワクチンという、より戦略的な代替手段を提供するように変化しています。ワクチンは抗生物質を使わずに鳥を細菌感染から守り、AMRを減少させます。メーカーは、サルモネラや大腸菌のような一般的な家禽疾病をターゲットとしたワクチンの製造に動向しています。このようなワクチンは細菌感染を抑えるのに役立つが、耐性を助長することはないです。政府や消費者が清潔で安全な食肉製品を求める中、この動向は重要です。
• 組み換えワクチンとDNAベースワクチン：鶏肉業界では、組み換えワクチンやDNAベースのワクチンの使用が増加しています。こうしたワクチンは、開発された細菌の種類に特異的であり、効率的に作用します。一般的に副作用も少ないです。生きている病原体が存在しないにもかかわらず、良好な免疫反応を引き起こすことができるため、家禽や消費者に対する安全性が向上します。さらに、DNAワクチンは製造や規模拡大が容易であるため、大規模な養鶏事業、特に新興国市場においては、比較的安価で導入することができます。
• カスタマイズ可能な多系統ワクチン：複数の細菌性病原体に対する広範な防御のための効果的なツールとなる、カスタマイズ可能な多系統ワクチンの開発が普及しつつあります。多系統ワクチンは、1回のワクチン接種で様々な細菌性疾病に対する家禽の免疫力を提供するため、今日、より求められています。これにより、ワクチン接種の必要性が削減され、養鶏場のワクチン接種が効率化されます。
• ワクチン送達システムの革新：ワクチン送達システムの革新は、家禽ワクチン市場において最も重要な動向となりつつあります。従来の注射法に代わり、経口ワクチンや水ベースの送達システムなど、より効率的でストレスの少ない方法が検討されています。これらにより、取り扱い時間の短縮、鳥へのストレスの軽減、全体的な福祉の向上、そしてより良いワクチンの摂取が可能となります。ワクチン送達の革新はまた、より良いカバー率とより正確な投与を保証し、特に大規模な養鶏におけるワクチン接種キャンペーンの全体的な成功につながります。
• 政府の支援と規制の強化：世界中の政府は、家禽の健康とワクチン使用の規制において、より積極的な役割を果たしています。食品の安全性と疾病予防に対する懸念が高まるにつれ、ほとんどの国で、特に細菌性疾病に関する家禽のワクチン接種に対する規制が強化されることになります。このような規制強化の動きは、国の疾病対策プログラムの一環としてのワクチン需要を強制するものです。さらに、各国政府はワクチン技術の研究開発をますます支援するようになっており、そのためメーカーは厳しい安全性と有効性の基準を満たす新しいワクチン製剤に投資するようになっています。

抗菌剤耐性予防への注力、組み換えワクチン、多系統ワクチン製剤、ワクチンデリバリーの革新、政府支援の強化など、家禽用細菌病ワクチン市場の新たな動向は、業界を大きく再構築しています。これらの動向は、家禽の健康状態を改善し、疾病対策への取り組みを強化し、抗生物質を使用しないより安全な家禽生産に貢献しています。

家禽用細菌病ワクチン市場の最近の動向

家禽用細菌病ワクチン市場は、メーカーや研究者が家禽の細菌感染という課題に取り組む中で、大きな発展を遂げています。最近の動向は、ワクチンの有効性の向上、入手可能性の拡大、抗生物質への依存度の低減に重点が置かれています。以下の開発は、家禽の健康のニーズを満たすために業界がどのように進化しているかを浮き彫りにしています。

• 組み換えワクチン技術の進歩：組み換えワクチンは、家禽用細菌病ワクチンのダイナミクスを変えつつあります。組換えワクチン製造における遺伝子工学は、生きた病原体を利用する従来の道を歩むことなく、特定の株で使用するためのより安全で効果的な製品を開発します。その特異性の高さと副作用の低減が、これらの組み換えワクチンの普及に貢献し、サルモネラ菌や大腸菌、マイコプラズマ感染症から鳥類を守る免疫対策として徐々に普及しています。
• 新興市場でのワクチン開拓：新市場では、手ごろな価格で入手しやすい家禽用ワクチンの需要が高まっています。メーカー各社は、これらのワクチンをより大きな市場でも利用できるようにすることで、この需要を満たしています。比較的低コストで、大規模な養鶏場に理想的な新しいワクチン製剤が出現しつつあります。このような拡大は、家禽の生産量は多いが獣医療へのアクセスが限られている地域の細菌性疾病をコントロールするために不可欠です。また、食の安全と家禽の健康を確保するための世界の取り組みにも役立ちます。
• ワクチン送達システムの改善：ワクチン送達システムにおける新たな技術革新は、ワクチン接種の効率を向上させ、家禽へのストレスを軽減するのに役立っています。経口ワクチンや水性ワクチンは、投与が容易で、処理時間を短縮できる方法として現在開発中です。これらのシステムは大規模な養鶏場にとって、人件費を削減し、より均一なワクチン分布を確保できるため有利です。改良された供給システムの採用により、ワクチン接種率は向上し、疾病予防と家禽全体の健康状態が改善されています。
• 政府と民間セクターのコラボレーション：家禽細菌病ワクチンの処方と配布の分野では、政府とその他の民間部門との協力が重要になってきています。官民パートナーシップは、ワクチン製造の加速化と、国内における普遍的ワクチン接種プログラムの制度化を促進しています。政府は研究開発を支援し、規制上の認可を与え、草の根レベルで農家に供給する一方、民間セクターは技術的に進んだ地域や製造施設を提供しています。この統合は、多くの地域でワクチンの入手と実施に役立っています。
• 抗生物質不使用の家禽飼育へのシフト：消費者の意識と需要により、国際社会はより安全で健康的な抗生物質不使用の鶏肉製品の生産に注力せざるを得なくなっています。このような背景から、養鶏業界は抗生物質の使用ではなく、ワクチンに基づく疾病対策に重点を置くようになっています。メーカー各社は、幅広い細菌防御を提供するだけでなく、抗生物質を使用しないワクチンの製造に注力しています。この開発は、抗生物質耐性に関連する懸念に対処し、長期的な養鶏の持続可能性を確保する上で極めて重要です。

組換え技術の進歩、ワクチンの選択肢の拡大、送達システムの改善、官民の協力、抗生物質不使用の養鶏への注力など、家禽細菌病ワクチン市場における最近の動向は、業界を再構築しつつあります。これらの技術革新は家禽の健康を改善し、抗生物質への依存を減らし、世界中でより安全で持続可能な家禽生産を保証しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 背景と分類
• サプライチェーン

第3章 市場動向と予測分析

• マクロ経済の動向と予測
• 業界の促進要因と課題
• PESTLE分析
• 特許分析
• 規制環境

第4章 世界の家禽用細菌病ワクチン市場：タイプ別

• 概要
• タイプ別の魅力分析
• 生：動向と予測（2019～2031年）
• 弱毒：動向と予測（2019-2031年）
• 不活化：動向と予測（2019～2031年）

第5章 世界の家禽用細菌病ワクチン市場：用途別

• 概要
• 用途別の魅力分析
• NDV：動向と予測（2019-2031）
• マレック病：動向と予測（2019-2031年）
• IBD：動向と予測（2019-2031）
• 感染性気管支炎：動向と予測（2019～2031年）
• インフルエンザ：動向と予測（2019-2031）
• その他：動向と予測（2019-2031）

第6章 地域分析

• 概要
• 世界の家禽用細菌病ワクチン市場：地域別

第7章 北米の家禽用細菌病ワクチン市場

• 概要
• 北米の家禽用細菌病ワクチン市場：タイプ別
• 北米の家禽用細菌病ワクチン市場：用途別
• 米国の家禽用細菌病ワクチン市場
• メキシコの家禽用細菌病ワクチン市場
• カナダの家禽用細菌病ワクチン市場

第8章 欧州の家禽用細菌病ワクチン市場

• 概要
• 欧州の家禽用細菌病ワクチン市場：タイプ別
• 欧州の家禽用細菌病ワクチン市場：用途別
• ドイツの家禽用細菌病ワクチン市場
• フランスの家禽用細菌病ワクチン市場
• スペインの家禽用細菌病ワクチン市場
• イタリアの家禽用細菌病ワクチン市場
• 英国の家禽用細菌病ワクチン市場

第9章 アジア太平洋の家禽用細菌病ワクチン市場

• 概要
• アジア太平洋の家禽用細菌病ワクチン市場：タイプ別
• アジア太平洋の家禽用細菌病ワクチン市場：用途別
• 日本の家禽用細菌病ワクチン市場
• インドの家禽用細菌病ワクチン市場
• 中国の家禽用細菌病ワクチン市場
• 韓国の家禽用細菌病ワクチン市場
• インドネシアの家禽用細菌病ワクチン市場

第10章 世界のその他地域の家禽用細菌病ワクチン市場

• 概要
• 世界のその他地域の家禽用細菌病ワクチン市場：タイプ別
• 世界のその他地域の家禽用細菌病ワクチン市場：用途別
• 中東の家禽用細菌病ワクチン市場
• 南米の家禽用細菌病ワクチン市場
• アフリカの家禽用細菌病ワクチン市場

第11章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • 買い手の交渉力
  • 供給企業の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
• 市場シェア分析

第12章 機会と戦略分析

• バリューチェーン分析
• 成長機会分析
  • タイプ別の成長機会
  • 用途別の成長機会
• 世界の家禽用細菌病ワクチン市場の新たな動向
• 戦略分析
  • 新製品開発
  • 認証とライセンシング
  • 合併、買収、契約、提携、合弁事業

第13章 バリューチェーンにおける主要企業の企業プロファイル

• 競合分析
• Merck
• Boehringer Ingelheim
• Ceva
• Zoetis
• Vaxxinova（R）
• Elanco
• Qyh Biotech Co.
• Hester Biosciences
• Pulike
• Phibro Animal Health Corporation

第14章 付録

List of Figures

• Figure 1.1: Trends and Forecast for the Global Poultry Bacterial Disease Vaccine Market
• Figure 2.1: Usage of Poultry Bacterial Disease Vaccine Market
• Figure 2.2: Classification of the Global Poultry Bacterial Disease Vaccine Market
• Figure 2.3: Supply Chain of the Global Poultry Bacterial Disease Vaccine Market
• Figure 2.4: Driver and Challenges of the Poultry Bacterial Disease Vaccine Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Poultry Bacterial Disease Vaccine Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Poultry Bacterial Disease Vaccine Market ($B) by Type
• Figure 4.3: Forecast for the Global Poultry Bacterial Disease Vaccine Market ($B) by Type
• Figure 4.4: Trends and Forecast for Live in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 4.5: Trends and Forecast for Attenuated in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 4.6: Trends and Forecast for Killed in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 5.1: Global Poultry Bacterial Disease Vaccine Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Poultry Bacterial Disease Vaccine Market ($B) by Application
• Figure 5.3: Forecast for the Global Poultry Bacterial Disease Vaccine Market ($B) by Application
• Figure 5.4: Trends and Forecast for NDV in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 5.5: Trends and Forecast for Marek's Disease in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 5.6: Trends and Forecast for IBD in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 5.7: Trends and Forecast for Infectious Bronchitis in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 5.8: Trends and Forecast for Influenza in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 5.9: Trends and Forecast for Others in the Global Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 6.1: Trends of the Global Poultry Bacterial Disease Vaccine Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Poultry Bacterial Disease Vaccine Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 7.2: North American Poultry Bacterial Disease Vaccine Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Poultry Bacterial Disease Vaccine Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Poultry Bacterial Disease Vaccine Market ($B) by Type (2025-2031)
• Figure 7.5: North American Poultry Bacterial Disease Vaccine Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Poultry Bacterial Disease Vaccine Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Poultry Bacterial Disease Vaccine Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 8.2: European Poultry Bacterial Disease Vaccine Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Poultry Bacterial Disease Vaccine Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Poultry Bacterial Disease Vaccine Market ($B) by Type (2025-2031)
• Figure 8.5: European Poultry Bacterial Disease Vaccine Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Poultry Bacterial Disease Vaccine Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Poultry Bacterial Disease Vaccine Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 9.2: APAC Poultry Bacterial Disease Vaccine Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Poultry Bacterial Disease Vaccine Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Poultry Bacterial Disease Vaccine Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Poultry Bacterial Disease Vaccine Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Poultry Bacterial Disease Vaccine Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Poultry Bacterial Disease Vaccine Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Poultry Bacterial Disease Vaccine Market (2019-2031)
• Figure 10.2: ROW Poultry Bacterial Disease Vaccine Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Poultry Bacterial Disease Vaccine Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Poultry Bacterial Disease Vaccine Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Poultry Bacterial Disease Vaccine Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Poultry Bacterial Disease Vaccine Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Poultry Bacterial Disease Vaccine Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Poultry Bacterial Disease Vaccine Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Poultry Bacterial Disease Vaccine Market
• Figure 11.2: Market Share (%) of Top Players in the Global Poultry Bacterial Disease Vaccine Market (2024)
• Figure 12.1: Growth Opportunities for the Global Poultry Bacterial Disease Vaccine Market by Type
• Figure 12.2: Growth Opportunities for the Global Poultry Bacterial Disease Vaccine Market by Application
• Figure 12.3: Growth Opportunities for the Global Poultry Bacterial Disease Vaccine Market by Region
• Figure 12.4: Emerging Trends in the Global Poultry Bacterial Disease Vaccine Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Poultry Bacterial Disease Vaccine Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Poultry Bacterial Disease Vaccine Market by Region
• Table 1.3: Global Poultry Bacterial Disease Vaccine Market Parameters and Attributes
• Table 3.1: Trends of the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 3.2: Forecast for the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Poultry Bacterial Disease Vaccine Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 4.4: Trends of Live in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 4.5: Forecast for Live in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 4.6: Trends of Attenuated in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 4.7: Forecast for Attenuated in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 4.8: Trends of Killed in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 4.9: Forecast for Killed in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Poultry Bacterial Disease Vaccine Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 5.4: Trends of NDV in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 5.5: Forecast for NDV in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 5.6: Trends of Marek's Disease in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 5.7: Forecast for Marek's Disease in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 5.8: Trends of IBD in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 5.9: Forecast for IBD in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 5.10: Trends of Infectious Bronchitis in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 5.11: Forecast for Infectious Bronchitis in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 5.12: Trends of Influenza in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 5.13: Forecast for Influenza in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 5.14: Trends of Others in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 5.15: Forecast for Others in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 7.1: Trends of the North American Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 7.2: Forecast for the North American Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 8.1: Trends of the European Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 8.2: Forecast for the European Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 9.1: Trends of the APAC Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 9.2: Forecast for the APAC Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 10.1: Trends of the ROW Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 10.2: Forecast for the ROW Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Poultry Bacterial Disease Vaccine Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Poultry Bacterial Disease Vaccine Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Poultry Bacterial Disease Vaccine Market (2019-2031)
• Table 11.1: Product Mapping of Poultry Bacterial Disease Vaccine Suppliers Based on Segments
• Table 11.2: Operational Integration of Poultry Bacterial Disease Vaccine Manufacturers
• Table 11.3: Rankings of Suppliers Based on Poultry Bacterial Disease Vaccine Revenue
• Table 12.1: New Product Launches by Major Poultry Bacterial Disease Vaccine Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Poultry Bacterial Disease Vaccine Market

The future of the global poultry bacterial disease vaccine market looks promising with opportunities in the NDV, Marek's disease, IBD, infectious bronchitis, and influenza markets. The global poultry bacterial disease vaccine market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the rising demand for poultry products, the growing awareness of animal health, and regulatory requirements.

• Lucintel forecasts that, within the type category, killed will remain the largest segment over the forecast period due to its widespread acceptance for poultry disease prevention.
• Within the application category, infectious bronchitis will remain the largest segment due to its high prevalence and impact on poultry health.
• In terms of region, APAC is expected to witness the highest growth over the forecast period due to high poultry production.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Poultry Bacterial Disease Vaccine Market

With rising attention on poultry health and its dependency on the use of antibiotics, the worldwide poultry bacterial disease vaccine market is changing with various emerging trends. There are innovations going on in terms of vaccine technology and growing concern for food safety as well. Trends that are in focus for further modification of the poultry bacterial disease market are as follows:

• Prevention of AMR: The issue of antimicrobial resistance places the poultry industry at a crossroads, and the sector has been changing to provide a more strategic alternative: vaccines. Vaccines protect birds from bacterial infections without antibiotics, reducing AMR. Manufacturers have trended toward the production of vaccines that target common poultry diseases such as Salmonella and E. coli. Such a vaccine helps keep bacterial infection at bay but does not encourage resistance. This trend is significant as governments and consumers call for clean and safe meat products.
• Recombinant and DNA-Based Vaccines: The use of recombinant and DNA-based vaccines is on the rise in the poultry industry. Such vaccines are specific and work efficiently with respect to the bacterial type for which they have been developed. They generally have minimal side effects. Their safety to poultry and consumers is enhanced because they are able to elicit a good immune response, but in the absence of live pathogens. Furthermore, DNA vaccines are easier to produce and scale, hence are relatively cheaper for large-scale poultry farming operations, especially in developing markets.
• Customizable and Multi-Strain Vaccines: The development of customizable and multi-strain vaccines that would be an effective tool for broad protection against several bacterial pathogens is increasing in prevalence. Multi-strain vaccines are more sought after today since they provide poultry immunity to a variety of bacterial diseases by taking one vaccine dose. This cuts the need for vaccination and streamlines the vaccination of poultry farms.
• Innovation in Vaccine Delivery Systems: Vaccine delivery systems innovation is becoming the most significant trend in the poultry vaccine market. Replacing the traditional injection methods, more efficient and less stressful methods, such as oral vaccines and water-based delivery systems, are being considered. These have a reduced time of handling, stress to the birds, and overall welfare improvement, and better vaccine uptake. Vaccine delivery innovations also ensure there is better coverage and more accurate dosing, leading to the overall success of campaigns for vaccination, especially in poultry farming on large scales.
• Increased Government Support and Regulation: Governments around the world are playing a more active role in regulating poultry health and vaccine use. As concerns over food safety and disease prevention grow, most countries will have stronger regulations for vaccination in their poultry, especially regarding bacterial diseases. This regulatory push is forcing the demand for vaccines as part of national disease control programs. Moreover, governments are increasingly supporting research and development in vaccine technology, which is making manufacturers invest in new vaccine formulations that meet strict safety and efficacy standards.

The emerging trends in the poultry bacterial disease vaccine market, including the focus on antimicrobial resistance prevention, recombinant vaccines, multi-strain formulations, vaccine delivery innovations, and increased government support, are significantly reshaping the industry. These trends are improving poultry health, enhancing disease control efforts, and contributing to safer, antibiotic-free poultry production.

Recent Developments in the Poultry Bacterial Disease Vaccine Market

The poultry bacterial disease vaccine market is undergoing significant development as manufacturers and researchers work to address the challenges of bacterial infections in poultry. Recent developments are focused on improving vaccine efficacy, expanding accessibility, and reducing reliance on antibiotics. The following developments highlight how the industry is evolving to meet the needs of poultry health.

• Advances in Recombinant Vaccine Technology: Recombinant vaccines are changing the dynamics of poultry bacterial disease vaccines. Genetic engineering in producing recombinant vaccines develops a safer, more effective product for use by specific strains without having to go through the traditional path of utilizing live pathogens. Their specificity level and reduced side effects contribute to the gain of these recombinant vaccines, making them progressively popular for immunity protection of birds from Salmonella and E. coli, and Mycoplasma infections, thus improving poultry health as well as reducing the need for antibiotics.
• Vaccine Development in New Markets: There is an increased demand for affordable and accessible poultry vaccines in new markets. Manufacturers are fulfilling this demand by making these vaccines accessible to larger markets. New vaccine formulations are emerging that are of relatively low cost and ideal for large poultry farms. This expansion is vital for controlling bacterial diseases in regions with high poultry production but limited access to veterinary care. It also helps in global efforts to ensure food safety and poultry health.
• Improved Vaccine Delivery Systems: New innovations in vaccine delivery systems are helping to improve the efficiency of vaccination, thus reducing the stress on poultry. Oral vaccines and water-based vaccines are methods that are currently being developed for easy administration, thereby reducing handling time. The systems are advantageous for large poultry farms, as they decrease labor costs and ensure more uniform distribution of the vaccine. Vaccination coverage has increased due to the adoption of improved delivery systems, resulting in better disease prevention and overall poultry health.
• Collaborations Between Government and Private Sector: Collaboration between governments and other private sector units is becoming important in the area of poultry bacterial disease vaccine formulation and distribution. Public-Private Partnerships are facilitating acceleration in vaccine production and the institutionalization of universal vaccination programs in the country. Governments are supporting R&D, providing regulatory clearances, and supplies to farmers at the grassroots level, whereas the private sector is bringing technologically advanced areas and manufacturing facilities. This integration is helping with vaccine availability and implementation across many regions.
• Shift toward Raising Antibiotic-Free Poultry: Consumer awareness and demand are forcing the international community to concentrate on producing safer and healthier antibiotic-free poultry products. This aspect is encouraging the poultry industry to focus on vaccine-based disease control instead of antibiotic use. There has been a focus from manufacturers on making vaccines that not only offer broad-spectrum bacterial protection but do not involve antibiotic drugs. This development is crucial in addressing the concerns associated with antibiotic resistance and ensuring the sustainability of poultry farming in the long term.

Recent developments in the poultry bacterial disease vaccine market, such as advancements in recombinant technology, expanded vaccine options, improved delivery systems, public-private collaborations, and a focus on antibiotic-free poultry production, are reshaping the industry. These innovations are improving poultry health, reducing reliance on antibiotics, and ensuring safer, more sustainable poultry production worldwide.

Strategic Growth Opportunities in the Poultry Bacterial Disease Vaccine Market

The global poultry bacterial disease vaccine market is expected to grow with increased poultry production and heightened awareness about disease prevention. Strategic growth opportunities exist across a number of key applications, such as joint efforts in improving poultry health, increasing vaccine access, and reducing the impact of bacterial diseases. The following sections identify five key growth opportunities in the market.

• Development of Tailored Vaccines for Emerging Markets: One major growth area is in the case of emerging markets, such as poultry bacterial disease vaccines. Regions with difficulties and limited veterinary services in regard to disease control constitute a critical gap that can be exploited through designing cost-effective, region-specific vaccines for the specific needs of poultry farms. Manufacturers would improve poultry health by making the vaccine more accessible at a low price in production-intensive, but resource-poor, regions.
• Expansion of Vaccine Delivery Innovations: Innovations in vaccine delivery systems, such as oral vaccines and water-based delivery methods, represent a major growth opportunity. These systems offer a less invasive and more efficient way to vaccinate large flocks, reducing stress on poultry and improving vaccine uptake. Expanding the use of these delivery methods, particularly in large-scale poultry operations, will improve vaccination coverage and lead to better disease prevention and poultry health management.
• Inter-government, inter-institutional, and public-private collaborations in research and development will provide significant growth opportunities in the poultry vaccine market. Inter-government, inter-institutional, and public-private collaboration in research and development will facilitate accelerating the development of new vaccine formulations, development of more effective vaccines, and expansion of the coverage of vaccination programs. With joint resources and expertise, stakeholders can leverage their differences and challenge barriers toward developing safe and efficacious vaccines for poultry worldwide.
• Focus on Sustainable and Antibiotic-Free Poultry Production: With the rising demand for antibiotic-free poultry, manufacturers will find a good opportunity to develop vaccines that prevent bacterial diseases without antibiotics. Consumers' growing desire for safer and more sustainable meat products will lead to further demand for vaccines as an alternative to antibiotics. Therefore, this trend toward antibiotic-free production methods will drive growth in the poultry bacterial disease vaccine market.
• Increase Support towards Poultry Health Programs: Growth opportunities for vaccine manufacturers to improve poultry health arise from initiatives undertaken by governments. Stricter regulations and guidelines for countries in terms of poultry disease prevention are creating immense pressure to put effective vaccination programs in place, thus creating further opportunities for manufacturers by being aligned to national health initiatives and providing vaccines that are of regulatory requirement quality. By contributing to these public health programs, vaccine manufacturers can expand market presence and achieve better disease control worldwide.

Strategic growth opportunities in the poultry bacterial disease vaccine market are centered around developing tailored vaccines for emerging markets, expanding vaccine delivery innovations, fostering research collaborations, focusing on antibiotic-free production, and supporting government health initiatives. These opportunities will drive market expansion while improving poultry health and ensuring safer, more sustainable poultry production.

Poultry Bacterial Disease Vaccine Market Driver and Challenges

The global poultry bacterial disease vaccine market is driven by several technological, economic, and regulatory drivers and challenges. These factors determine the development, production, and distribution of vaccines intended to improve poultry health and reduce bacterial infections. Understanding these drivers and challenges will help in the navigation of the market dynamics.

The factors responsible for driving the poultry bacterial disease vaccine market include:

1. Technological Advancements in Vaccine Development: Advances in vaccine development technology, for instance, recombinant DNA and developed vaccine delivery systems, are key factors of this market. Such advancements provide more effective vaccines and the immunity that results from them, especially against certain strains of bacteria, help poultry be better managed for health and productivity.

2. Increased demand for antibiotic-free poultry: Increasing consumer preference for antibiotic-free poultry is driving demand for vaccines as an alternative to antibiotics in disease prevention. Vaccines help protect poultry from bacterial infections without contributing to antimicrobial resistance, aligning with consumer expectations for safer, healthier meat products. This shift is encouraging the adoption of vaccines in the poultry industry.

3. Government Regulations and Health Initiatives: Demand for poultry bacterial disease vaccines is mainly driven by more stringent government regulations in the area of poultry health and disease prevention. Most governments have adopted vaccination programs and higher standards for poultry disease control, thereby increasing the usage of vaccines in poultry farms worldwide.

4. Increase in Poultry Production: In such a scenario of increasing global poultry production, disease prevention measures must become more effective. The growing demand for poultry products is pushing for the use of vaccines as a means to control bacterial diseases and reduce mortality with an improvement in overall flock health.

5. Food Safety and Public Health Awareness are on the Rise: Heightened awareness of food safety and public health concerns is increasing the demand for vaccines in poultry farming. Consumers are more aware of the potential risks associated with bacterial infections in poultry, which has led to a greater emphasis on preventive measures, including vaccination.

Challenges in the poultry bacterial disease vaccine market are:

1. High Cost of Vaccine Development: The main barrier in the poultry bacterial disease vaccine market is the high cost of developing a new vaccine. Research and development require a lot of time, resources, and expertise. This usually proves to be a challenge for smaller companies to venture into the market and provide vaccines for farmers in developing countries.

2. Issues Surrounding Vaccine Distribution and Storage: Efficient distribution and storage of vaccines, especially in regions with limited infrastructure, remain a challenge. Vaccines often require specific storage conditions, such as refrigeration, which can complicate their distribution in rural areas or developing countries. Overcoming these logistical hurdles is essential for ensuring broad vaccine access.

3. Limited Vaccine Efficacy for Some Strains: Another challenge is the limited efficacy of vaccines for certain bacterial strains. While vaccines for some diseases, such as Salmonella, are widely available, there are still gaps in vaccine development for less common bacterial pathogens. Further research is needed to develop vaccines that offer broad protection against a wider range of bacteria.

Drivers for the global poultry bacterial disease vaccine include recent advances in technology, increasing consumer demand for antibiotic-free poultry, government regulations, and growth in poultry production. There is also awareness of food safety. The market growth would be a hurdle against some of the challenges including the high cost of vaccine development, issues of distribution and storage, as well as the limited efficacy for certain strains. These challenges would have to be addressed in order to extend and increase the poultry vaccines' global reach and impact.

List of Poultry Bacterial Disease Vaccine Companies

• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, poultry bacterial disease vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the poultry bacterial disease vaccine companies profiled in this report include:
• Merck
• Boehringer Ingelheim
• Ceva
• Zoetis
• Vaxxinova(R)
• Elanco
• Qyh Biotech Co.
• Hester Biosciences
• Pulike
• Phibro Animal Health Corporation

Poultry Bacterial Disease Vaccine Market by Segment

The study includes a forecast for the global poultry bacterial disease vaccine market by type, application, and region.

Poultry Bacterial Disease Vaccine Market by Type [Value from 2019 to 2031]:

• Live
• Attenuated
• Killed

Poultry Bacterial Disease Vaccine Market by Application [Value from 2019 to 2031]:

• NDV
• Marek's Disease
• IBD
• Infectious Bronchitis
• Influenza
• Others

Poultry Bacterial Disease Vaccine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Poultry Bacterial Disease Vaccine Market

The global poultry bacterial disease vaccine market has grown by leaps and bounds with the increased demand for poultry health management and the rising awareness of the importance of disease prevention. Bacterial diseases such as Salmonella, Escherichia coli, and Pasteurella are significant threats to poultry production and have led to increased demand for effective vaccines. Technological advancements in the formulation of vaccines, along with effective regulatory frameworks, have also paved the way for market growth. The United States, China, Germany, India, and Japan are key leaders in this market, all developing innovative solutions to curb bacterial diseases among poultry.

• United States: In the United States, the market for poultry bacterial disease vaccines has grown with great inventions in vaccine technology. The USDA has been very crucial in promoting the licensing and utilization of vaccines for protection against a wide range of bacterial infections of poultry. Manufacturers of vaccines in the U.S. are now focusing on the advanced formulations of live attenuated vaccines and subunit vaccines for particular pathogens. This has also steered the emphasis towards vaccine development as part of the broader strategy aimed at reducing antibiotic use in poultry. These innovations help to improve the health of poultry and ensure safety in poultry products.
• China: China is the world's largest producer and consumer of poultry. The poultry bacterial disease vaccine market is gaining considerable momentum. This is also because of the rapid growth of the country in the poultry production sectors, where more effective strategies in disease prevention have been increased. Chinese manufacturers increasingly adopt modern vaccine technologies, such as recombinant DNA vaccines, in combating bacterial diseases such as Salmonella and E. coli. Furthermore, the government in China has placed stricter regulations regarding poultry health, hence pushing the demand for effective vaccines. Local research and development activities also help generate affordable vaccines, which are essential for small- and medium-sized poultry farms.
• Germany: Germany is one of the leading poultry bacterial disease vaccine markets in Europe, known for its strict regulation and advanced technologies of vaccines. In Germany, local manufacturers are designing multi-strain vaccines that can cover a wide variety of bacterial pathogens, including Pasteurella and E. coli. The country's strong research and development ecosystem ensures that vaccines will continue to be innovated against both national and international standards. A growing consumer preference in the German market for sustainably produced poultry is forcing market forces toward the adoption of more sustainable applications through vaccines, which minimize antibiotic use and improve poultry health in an environmentally friendlier manner.
• India: The Indian poultry bacterial disease vaccine market is developing because of India's thriving poultry industry. The country is facing significant challenges related to poultry diseases. In rural and semi-urban areas, veterinary care is not easily available. In turn, the demand for affordable and effective vaccines is increasing rapidly. Indian manufacturers are targeting low-cost vaccines that are also multi-valent against bacterial diseases, such as Salmonella and Avian Cholera. The government also supports vaccination programs in poultry for healthy production, which has a direct bearing on food safety and the economics of the poultry industry.
• Japan: Japan is known for its development of advanced and highly specific poultry health vaccines. The market is highly competitive, mainly due to the strict regulatory requirements and emphasis on biosecurity that Japan sets. Companies in Japan are using advanced biotechnologies for developing specific-strain vaccines against bacteria, such as Mycoplasma gallisepticum and E. coli. Consumers' increasing demand for safe, antibiotic-free poultry products is another market driver. With the emphasis of the country on technological advancements and high-quality production standards, Japan's poultry vaccine market keeps innovating in order to guarantee the healthiness of its poultry industry.

Features of the Global Poultry Bacterial Disease Vaccine Market

• Market Size Estimates: Poultry bacterial disease vaccine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Poultry bacterial disease vaccine market size by type, application, and region in terms of value ($B).
• Regional Analysis: Poultry bacterial disease vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the poultry bacterial disease vaccine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the poultry bacterial disease vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the poultry bacterial disease vaccine market by type (live, attenuated, and killed), application (NDV, Marek's disease, IBD, infectious bronchitis, influenza, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Poultry Bacterial Disease Vaccine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Live: Trends and Forecast (2019-2031)
• 4.4 Attenuated: Trends and Forecast (2019-2031)
• 4.5 Killed: Trends and Forecast (2019-2031)

5. Global Poultry Bacterial Disease Vaccine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 NDV: Trends and Forecast (2019-2031)
• 5.4 Marek's Disease: Trends and Forecast (2019-2031)
• 5.5 IBD: Trends and Forecast (2019-2031)
• 5.6 Infectious Bronchitis: Trends and Forecast (2019-2031)
• 5.7 Influenza: Trends and Forecast (2019-2031)
• 5.8 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Poultry Bacterial Disease Vaccine Market by Region

7. North American Poultry Bacterial Disease Vaccine Market

• 7.1 Overview
• 7.2 North American Poultry Bacterial Disease Vaccine Market by Type
• 7.3 North American Poultry Bacterial Disease Vaccine Market by Application
• 7.4 United States Poultry Bacterial Disease Vaccine Market
• 7.5 Mexican Poultry Bacterial Disease Vaccine Market
• 7.6 Canadian Poultry Bacterial Disease Vaccine Market

8. European Poultry Bacterial Disease Vaccine Market

• 8.1 Overview
• 8.2 European Poultry Bacterial Disease Vaccine Market by Type
• 8.3 European Poultry Bacterial Disease Vaccine Market by Application
• 8.4 German Poultry Bacterial Disease Vaccine Market
• 8.5 French Poultry Bacterial Disease Vaccine Market
• 8.6 Spanish Poultry Bacterial Disease Vaccine Market
• 8.7 Italian Poultry Bacterial Disease Vaccine Market
• 8.8 United Kingdom Poultry Bacterial Disease Vaccine Market

9. APAC Poultry Bacterial Disease Vaccine Market

• 9.1 Overview
• 9.2 APAC Poultry Bacterial Disease Vaccine Market by Type
• 9.3 APAC Poultry Bacterial Disease Vaccine Market by Application
• 9.4 Japanese Poultry Bacterial Disease Vaccine Market
• 9.5 Indian Poultry Bacterial Disease Vaccine Market
• 9.6 Chinese Poultry Bacterial Disease Vaccine Market
• 9.7 South Korean Poultry Bacterial Disease Vaccine Market
• 9.8 Indonesian Poultry Bacterial Disease Vaccine Market

10. ROW Poultry Bacterial Disease Vaccine Market

• 10.1 Overview
• 10.2 ROW Poultry Bacterial Disease Vaccine Market by Type
• 10.3 ROW Poultry Bacterial Disease Vaccine Market by Application
• 10.4 Middle Eastern Poultry Bacterial Disease Vaccine Market
• 10.5 South American Poultry Bacterial Disease Vaccine Market
• 10.6 African Poultry Bacterial Disease Vaccine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Poultry Bacterial Disease Vaccine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Merck
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Boehringer Ingelheim
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Ceva
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Zoetis
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Vaxxinova(R)
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Elanco
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Qyh Biotech Co.
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Hester Biosciences
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Pulike
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Phibro Animal Health Corporation
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us